In HIV patients with belly fat who responded to tesamorelin, denser visceral fat (on CT scans) was associated with less visceral fat area, showing that fat quality and quantity are related.

Pro

Against

Evidence from Studies

Supporting (1)

Community contributions welcome

Tesamorelin improves fat quality independent of changes in fat quantity

Randomized Controlled Trial

Human

When people with HIV took tesamorelin, their belly fat got less in amount but became denser and healthier — meaning less fat packed into smaller, better cells.

Contradicting (0)

Community contributions welcome

No contradicting evidence found

Source Study

Tesamorelin improves fat quality independent of changes in fat quantity

Score: 66

DOI: 10.1097/qad.0000000000002897

Similar Assertions

When HIV patients with belly fat responded to tesamorelin, thicker visceral fat (as seen on CT scans) was linked to higher levels of adiponectin, a hormone that helps regulate metabolism.

97%

For HIV patients with belly fat who responded to tesamorelin, denser subcutaneous fat (on CT scans) was linked to less subcutaneous fat area, showing that fat quality and quantity are related.

96%

When HIV patients on tesamorelin had denser belly fat, their bodies also produced more adiponectin, a hormone that helps regulate metabolism, showing a link between fat quality and metabolic health.

95%

In HIV patients with belly fat who responded to tesamorelin, thicker subcutaneous fat (on CT scans) was linked to higher adiponectin levels, which is beneficial for metabolic health.

92%

Only HIV patients whose belly fat shrinks by at least 8% after taking this drug also get healthier-looking fat on scans — others don’t benefit in this way.

91%